BETABiohacksAI is a research tool for informational purposes only. All outputs are computational hypothesis candidates — not confirmed mechanisms, not medical advice, and not a substitute for professional medical judgment. Independent experimental validation is always required.
BiohacksAI is an evolving scientific literature platform. New compounds and evidence are indexed continuously.
B
○

Cep 32496

0+ PubMed studies analyzed

Similar Compounds by Shared Targets

The following compounds share molecular targets with Cep 32496, based on binding affinity data from BindingDB and ChEMBL. Sorted by shared target overlap.

bafetinib
21 shared targets
regorafenib
20 shared targets
tivozanib
21 shared targets
golvatinib
21 shared targets
ponatinib
29 shared targets
dasatinib
17 shared targets
cabozantinib
18 shared targets
nilotinib
25 shared targets
saracatinib
21 shared targets
doramapimod
28 shared targets
Loading evidence profile...

This evidence profile for Cep 32496 is generated deterministically from 0 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.

Data source: PubMed/MEDLINE (NLM). Corpus version: v20260227-01. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.